November 30, 2016 at Davis Polk & Wardwell, 450 Lexington Avenue, New York (Pre-Conference)
December 1, 2016 at 10 on the Park, 60 Columbus Circle, New York
The conference is full. For last minute Investor and large company BD&L registrations, please contact us via email (click here) - thank you!
is an investor and partnering conference gathering healthcare technology executives and investors from the Nordic countries (Sweden, Norway, Finland and Denmark) and North America. The conference connects promising, innovative healthcare technology companies and Nordic Life Science organizations with investors, external innovation scouts and business developers in the U.S.
The target audience includes Pharma/Biotech, Diagnostics, Medtech and Digital Health.
Pre-Conference Workshop for the Nordic Companies on November 30:
On November 30, a Pre-Conference Workshop day is held exclusively for the attending Nordic companies. Please see the Agenda for more information.
Sanofi-Genzyme BioVentures, Pfizer Venture Investments, ARCH Ventures, OrbiMed, Boehringer Ingelheim Venture Fund, MPM Capital, Aisling Capital, AbbVie Ventures, Broadview Ventures, New Enterprise Associates, Philips Ventures, MVM Life Science Partners, Altaris Capital Partners, Aporia Advisors, H.I.G. Capital, Fountain Healthcare Partners, Citadel LLC/Surveyor Capital, MSF Capital Advisors, Solar Capital, Baker Bros. Advisors, MedPro Investors, GC Finance, Federated Investors, Lerner Associates, Magid Family Office, HealthCap, Industrifonden, Serendipity Partners, Citigroup, Deutsche Bank
Alexion Pharmaceuticals, Mylan, Regeneron, Pfizer, Roche Innovation Center New York, Bristol-Myers Squibb, LabCorp, Teleflex, IBM Watson Health, The New York Stem Cell Foundation
DNB, NASDAQ, Davis Polk & Wardwell, The Trout Group and Dentons - with more to come!
|Registration||6 Jul – 21 Nov|
|Meeting Selection||27 Oct – 1 Dec|
|Venue||60 Columbus Circle